Dexterra Group Inc.
HZNOF
$5.40
-$0.151-2.72%
| Weiss Ratings | HZNOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Reward Grade | B- | |||
| Rating Factors | HZNOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | HZNOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.34 | |||
| Price History | HZNOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.72% | |||
| 30-Day Total Return | -3.01% | |||
| 60-Day Total Return | 3.19% | |||
| 90-Day Total Return | 18.89% | |||
| Year to Date Total Return | -2.11% | |||
| 1-Year Total Return | 20.88% | |||
| 2-Year Total Return | 31.58% | |||
| 3-Year Total Return | -14.08% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -5.76% | |||
| 52-Week Low % Change | 41.36% | |||
| Price | HZNOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $5.73 | |||
| 52-Week Low Price | $3.82 | |||
| 52-Week Low Price (Date) | Jul 10, 2024 | |||
| 52-Week High Price (Date) | Feb 14, 2025 | |||
| Valuation | HZNOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 326.65M | |||
| Enterprise Value | 409.79M | |||
| Price/Earnings (TTM) | 37.29 | |||
| Earnings Per Share (TTM) | 0.14 | |||
| Earnings Per Share Growth | -45.91% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.46 | |||
| Price/Book (Q) | 1.66 | |||
| Enterprise Value/Revenue (TTM) | 0.56 | |||
| Price | $5.40 | |||
| Enterprise Value/EBITDA (TTM) | 6.54 | |||
| Enterprise Value/EBIT | 10.52 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | HZNOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 64.27M | |||
| Dividend Yield | 4.67% | |||
| Div. Per Share (Most Recent) | $0.06 | |||
| Dividend Per Share (TTM) | $0.25 | |||
| Payout Ratio (TTM) | 178.63% | |||
| Dividend Per Share (Most Recent) | $0.06 | |||
| Company Info | HZNOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 416 483 5152 | |||
| Address | 5915 Airport Road Mississauga, ON L4V 1T1 | |||
| Website | dexterra.com | |||
| Country | Canada | |||
| Year Founded | 1985 | |||
| Profitability | HZNOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 5.30% | |||
| Profit Margin | 1.22% | |||
| Management Effectiveness | HZNOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 5.48% | |||
| Return on Equity | 10.20% | |||
| Income Statement | HZNOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 753.78M | |||
| Total Revenue (TTM) | 753.78M | |||
| Revenue Per Share | $11.73 | |||
| Gross Profit (TTM) | 104.43M | |||
| EBITDA (TTM) | 64.29M | |||
| EBIT (TTM) | 39.98M | |||
| Net Income (TTM) | 9.27M | |||
| Net Income Avl. to Common (TTM) | 9.27M | |||
| Total Revenue Growth (Q YOY) | -0.21% | |||
| Earnings Growth (Q YOY) | -5.49% | |||
| EPS Diluted (TTM) | 0.14 | |||
| EPS Diluted Growth (Q YOY) | -43.83% | |||
| Balance Sheet | HZNOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | -- | |||
| Cash Per Share (Q) | -- | |||
| Total Current Assets (Q) | 166.56M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 208.53M | |||
| Current Ratio (Q) | 1.464 | |||
| Book Value Per Share (Q) | $3.25 | |||
| Total Assets (Q) | 420.94M | |||
| Total Current Liabilities (Q) | 113.80M | |||
| Total Debt (Q) | 88.44M | |||
| Total Liabilities (Q) | 212.42M | |||
| Total Common Equity (Q) | 208.28M | |||
| Cash Flow | HZNOF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 9.51M | |||
| Cash from Financing (TTM) | -59.95M | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | 58.96M | |||
| Cash from Operations (TTM) | 50.45M | |||
